HomeETON • NASDAQ
Eton Pharmaceuticals Inc
add
$15.58
6.71%
After Hours:(0.00%)0.00
$15.58
Closed: Mar 14, 4:00:05 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 10.32M | 46.90% |
Operating expense | 5.79M | 17.01% |
Net income | 627.00K | 208.29% |
Net profit margin | 6.07 | 173.67% |
Earnings per share | 0.02 | 200.00% |
EBITDA | 787.00K | 320.45% |
Effective tax rate | -25.15% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.26M | -8.20% |
Total assets | 35.84M | 13.69% |
Total liabilities | 19.86M | 35.71% |
Total equity | 15.98M | — |
Shares outstanding | 25.84M | — |
Price to book | 23.55 | — |
Return on assets | 3.76% | — |
Return on capital | 6.59% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 627.00K | 208.29% |
Cash from operations | 2.95M | 238.14% |
Cash from investing | 0.00 | — |
Cash from financing | -385.00K | -4.34% |
Net change in cash | 2.57M | 409.33% |
Free cash flow | 805.25K | 241.75% |
Previous close
$14.60
Day range
$14.68 - $15.63
Year range
$3.03 - $18.41
Market cap
414.97M USD
Avg Volume
254.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Website
Employees
30
